Bleeding diathesis: Difference between revisions
Line 81: | Line 81: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|↓ | |↓ | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
|N | |||
| | | | ||
|- | |- | ||
Line 96: | Line 96: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|↓ | |↓ | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
|N | |||
| | | | ||
|- | |- | ||
Line 112: | Line 112: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|↓ | |↓ | ||
| | |N | ||
| | |N | ||
| | |N | ||
| | |↑ | ||
| | | | ||
|- | |- | ||
Line 130: | Line 130: | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 145: | Line 145: | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 162: | Line 162: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |↓ | ||
|↑ | |↑ | ||
| | |N | ||
| | |N | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 184: | Line 184: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|↓ | |||
| | | | ||
|N | |N | ||
|N | |N | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 208: | Line 208: | ||
|ɴ | |ɴ | ||
|ɴ | |ɴ | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 219: | Line 219: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | - | ||
| | |Rare | ||
| | |N/↓ | ||
| | |↑ | ||
| | |ɴ | ||
| | |ɴ | ||
|N | |||
| | | | ||
* AR inheritance | |||
* Absence of the platelet Gp IIb/IIIa receptor/ | |||
* Diminished for GP 2B-3A on [[Flow cytometry|f<abbr>low cytometry</abbr>]] | |||
|- | |- | ||
|[[Bernard-Soulier syndrome]] | |[[Bernard-Soulier syndrome]] | ||
| | | | ||
* Positive family history | * Positive family history | ||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
| - | |||
| - | |||
|N/↓ | |||
|↑ | |||
|N | |||
|N | |||
|N | |||
| | | | ||
* AR inheritance | |||
* Absence of the platelet Gp Ib-IX-V receptor | |||
* On PBS: giant platelets | |||
* Ristocetin - no aggregation | |||
|- | |- | ||
|[[Platelet storage pool deficiency|Platelet storage pool disorder (SPD)]] | |[[Platelet storage pool deficiency|Platelet storage pool disorder (SPD)]] | ||
Line 255: | Line 262: | ||
| | | | ||
| | | | ||
|N | |||
| | | | ||
* AD inheritance | |||
* Abnormalities of platelet granule formation | |||
|- | |- | ||
| colspan="2" |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | | colspan="2" |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ||
Line 273: | Line 282: | ||
| | | | ||
| | | | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 293: | Line 302: | ||
|↑ | |↑ | ||
|↑ | |↑ | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 319: | Line 328: | ||
| | | | ||
| | | | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 339: | Line 348: | ||
| | | | ||
| | | | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 428: | Line 437: | ||
|↑ | |↑ | ||
|N | |N | ||
| | |N | ||
|Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | ||
|- | |- | ||
Line 596: | Line 605: | ||
|↑ | |↑ | ||
|↑ | |↑ | ||
| | |N | ||
| | | | ||
|- | |- | ||
Line 620: | Line 629: | ||
|↑ | |↑ | ||
|Normal or mildly prolonged | |Normal or mildly prolonged | ||
| | |N | ||
| | | | ||
|- | |- |
Revision as of 18:22, 10 September 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2], Nazia Fuad M.D.
Overview
Bleeding diathesis is unusual susceptibility to bleed due to hypo-coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy; there are established laboratory tests, such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.
Homostasis
Hemostasis is the process of blood clot formation at the site of bleeding. This process has 4 main phases as below:
Platelet plug formation
Coagulation cascade
Antithrombotic control
Fibrinolysis
Classification
Disorders of hemostasis can be classified into two main categories: platelet disorders, and disorders of coagulation. Each category can be further classified as bellow:
Platelet disorders:
- Thrombocytopenia: platelet count less than 150,000 per mm3
- Thromobcytosis: platelet countcmore than 450,000 per mm3
- Qualitative Disorders of Platelet function such as Von Willebrand Disease, inherited or acquired functional disorders.
Coagulation disorders
- Vessel wall disorders: Endothelial cells are lining entire vessel walls all over the body. Endothelium is an active layer responsible for inflammatory responses, angiogenesis and blood cell interactions. Endothelial cells have a very important role in hemostasis and they are regulating blood fluidity by the balance of antithrombotic/prothrombotic and vasodilatory/vasoconstrictor effects.
- Metabolic and Inflammatory Disorders
- Inherited Disorders of the Vessel Wall
- Coagulation factor disorders:
- Fibrinogen deficiency
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- HK deficiency
- Prekallikrein deficiency
- Factor XIII deficiency
- Hemophilia
- Disseminated Intravascular Coagulation
- Vitamin K Deficiency
- Coagulation Disorders Associated with Liver Failure
- Acquired Inhibitors of Coagulation Factors
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | Comments | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Platelet count | Bleeding time (BT) | Prothrombin time (PT) | Activated partial thromboplastin time (aPTT) | Thrombin time (TT) | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | N | N | ||
Medications-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | N | N | ||||
Heparin-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | N | ↑ | ||||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | ||||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | ||||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | ↓ | ↑ | N | N | N | ||||
Hemolytic Uremic Syndrome | History of:
|
+ | + | + | + | + | ↓ | N | N | N | |||||
Thromobcytosis |
|
− | − | − | + | + | ↑ | Normal or slightly prolonged | ɴ | ɴ | N | ||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | - | Rare | N/↓ | ↑ | ɴ | ɴ | N |
| |
Bernard-Soulier syndrome |
|
+ | + | + | - | - | N/↓ | ↑ | N | N | N |
| |||
Platelet storage pool disorder (SPD) |
|
N |
| ||||||||||||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | + | N | ||||||||
Von Willebrand Disease |
|
+ | + | + | + | + | ↑ | Ν | ↑ | ↑ | N | ||||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
+ | + | +/- | - | - | N | ||||||
Inherited Disorders of the Vessel Wall |
|
+ | + | +/- | - | - | N | ||||||||
Coagulation factor disorders | Fibrinogen deficiency |
|
_ | + | + | + | N | ↑ | ↑ | ↑ | ↑ | The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | |||
Prothrombin deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | ↑ | ||||
Factor V deficiency |
|
_ | + | + | + | + | N | ↑ | ↑ | ↑ | N | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | N | ↑ | N | N | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | ||||||
Factor X deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | N | ||||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | N | N | ↑ | ↑ | N | ||||
HK deficiency | |||||||||||||||
Prekallikrein deficiency | |||||||||||||||
Factor XIII deficiency | |||||||||||||||
Hemophilia | Type A deficiency |
|
_ | _ | + | + | + | Unaffected | Unaffected | Unaffected | Prolonged | N | |||
Type B deficiency |
|
_ | _ | + | + | + | Unaffected | N | N | ↑ | N | ||||
Type C deficiency |
|
_ | _ | + | Rare | Rare | N | N | N | ↑ | N | ||||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | _ | + | + | ↓ | ↑ | ↑ | ↑ | N | |||
Vitamin K Deficiency |
|
+ | + | + | + | + | N | ↑ | ↑ | Normal or mildly prolonged | N | ||||
Coagulation Disorders Associated with Liver Failure | |||||||||||||||
Acquired Inhibitors of Coagulation Factors |
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | Plt levels | ||
---|---|---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | |||||||||
Type 2 | 2A | |||||||||
2B | ||||||||||
2M | ||||||||||
2N | ||||||||||
Type 3 |